Filed under: Forecasts , Politics My Armenian cousin Madeline called from France, as is her wont, monthly.

More here: 
U.S. health care reform: The view from France

Filed under: Earnings reports , Forecasts Dollar Tree Stores Inc. (NASDAQ: DLTR ), the nation’s leading operator of dollar stores, is scheduled to discuss its second-quarter 2009 results tomorrow morning in a conference call at 9:00 AM ET

See the original post:
Earnings preview: Dollar Tree still thriving in recession

Filed under: Stocks to Buy During the Chicago Bulls’ great run of NBA championships, Michael Jordan was once asked if he was worried about competing against an impressive Utah Jazz team in the finals one year. “Not really,” Jordan said. Likewise with my stance toward Frontline Ltd.

Original post:
Anything to worry about with Frontline? Not really

Filed under: Newspapers , Magazines , Private equity Vibe Media Group, publisher of hip-hop magazine Vibe , shut down in June, as the poor economy led to declining advertising revenue. Vibe has since been acquired for an undisclosed price by InterMedia Partners, a private equity firm. InterMedia said it plans to resume publication of Vibe in November as a quarterly magazine.

Read more from the original source:
Vibe and Creative Loafing: Private equity moves in print publishing

 Powered by Max Banner Ads 

Filed under: Stocks to Buy I guess Wall Street over did it a little bit, on the downside, with Tupperware earlier this year, driving shares down to about $11 in March. I caught the TUP train at $23.48 on April 28, 2009.

See original here: 
Tupperware makes up for the sell-off, and then some

Filed under: Bank of America (BAC) , Goldman Sachs Group (GS) The economic numbers are getting better, and every time the bears call an overbought market the market just gets even more overbought.

Here is the original post: 
Closing Bell: Even bulls are surprised at a lack of pullback (HGSI, BAC, GS, COCO)

Filed under: International markets , Newsletters , S and P 500 , DJIA , Recession “The stock market has now fulfilled our forecast made back in February for a rise to 9,000-10,000,” says Robert Prechter .

Original post:
Elliott Wave: Prechter prepares for next bear move

Filed under: JPMorgan Chase (JPM) , Goldman Sachs Group (GS) , Morgan Stanley (MS) , Federal Reserve , Cramer on BloggingStocks From TheStreet.com Network Bernanke to Get Second Term Citi’s No.

View post: 
Cramer on BloggingStocks: Bernanke halted the wipeout

Filed under: Options Theravance (NASDAQ: THRX ) biotechnology company closed at $15.22. THRX September volatility is at 65, October is at 72, December is at 78 verses its 26-week average of 78 according to Track Data, suggesting decreasing near term price movement. Seattle Genetics (NASDAQ: SGEN ) a clinical stage biotechnology company, closed at $12.09

Go here to read the rest:
Options Update: Clinical biotechnology stocks volatility near average